---
schema_version: "secwatch.filing_event.v1"
accession: "0000711404-22-000023"
form_type: "8-K"
ticker: "COO"
cik: "0000711404"
company_name: "COOPER COMPANIES, INC."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:15:47.852848+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CooperCompanies Q2 rev up 15% to $829.8M; GAAP EPS $2.55, adj EPS $3.24

## Summary
- CooperVision revenue $553.8M (+6% reported, +12% organic); toric and multifocal sales strong.
- CooperSurgical revenue $276.0M (+40% reported, +6% organic); fertility segment organic growth 15%.
- FY2022 guidance: revenue $3.28-3.312B, non-GAAP diluted EPS $13.09-13.29, reflecting FX headwinds.
- Exited contact lens solutions business in April; closed SightGlass JV with EssilorLuxottica in March.

## SEC filing metadata
- accession: 0000711404-22-000023
- form_type: 8-K
- ticker: COO
- cik: 0000711404
- company_name: COOPER COMPANIES, INC.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/711404/000071140422000023/0000711404-22-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/711404/000071140422000023/coo-20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000711404-22-000023
- JSON: https://secwatch.observer/filing/0000711404-22-000023.json
- Plain text: https://secwatch.observer/filing/0000711404-22-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.